Heart drug trial aims to quiet deadly rhythms in genetic heart disease
NCT ID NCT06174220
First seen Mar 20, 2026 · Last updated May 21, 2026 · Updated 8 times
Summary
This study tests an experimental drug called tideglusib in 120 people with a genetic form of heart muscle disease that raises the risk of dangerous heartbeats. Participants must have a specific gene change and at least 500 extra heartbeats per day. The goal is to see if the drug can reduce these extra beats and improve heart function over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARRHYTHMOGENIC CARDIOMYOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Hamilton General Hospital
RECRUITINGHamilton, Ontario, L8L 2X2, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Heart Health Institute Research Inc
RECRUITINGScarborough Village, Ontario, M1E 4B9, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Hopital du Sacré-Coeur de Montréal
NOT_YET_RECRUITINGMontreal, Quebec, H4J 1C5, Canada
Contact
Contact
Contact
-
Kingston General Hospital
NOT_YET_RECRUITINGKingston, Ontario, K7L 2V7, Canada
Contact
Contact
-
London Health Sciences Centre
RECRUITINGLondon, Ontario, N6A 5A5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
McGill University Health Centre
NOT_YET_RECRUITINGMontreal, Quebec, H4A 3J1, Canada
Contact
Contact
-
Montreal Heart Institute
RECRUITINGMontreal, Quebec, H1T 1C8, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
-
NL Health Services
RECRUITINGSt. John's, Newfoundland and Labrador, A1B 3V6, Canada
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Newmarket Electrophysiologist Research Group 'NERG'
NOT_YET_RECRUITINGNewmarket, Ontario, L3Y 2P9, Canada
Contact
Contact
-
Nova Scotia Health
RECRUITINGHalifax, Nova Scotia, B3H 2Y9, Canada
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
St. Michael's Hospital
NOT_YET_RECRUITINGToronto, Ontario, M5B 1W8, Canada
Contact
Contact
-
Sunnybrook Health Sciences Centre
NOT_YET_RECRUITINGToronto, Ontario, M4N 3M5, Canada
Contact
Contact
-
University Institute of Cardiology and Pneumology of Quebec
RECRUITINGQuébec, Quebec, G1V 4G5, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of British Columbia
RECRUITINGVancouver, British Columbia, V6Z 1Y6, Canada
Contact
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
University of Calgary
RECRUITINGCalgary, Alberta, T2N 2T9, Canada
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
University of Ottawa Heart Institute
NOT_YET_RECRUITINGOttawa, Ontario, K1Y 4W7, Canada
Contact
Contact
Contact
-
Victoria Cardiac Arrhythmia Trials Inc.
RECRUITINGVictoria, British Columbia, V8Z 0B9, Canada
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.